MELODY HELLSTEN to Immunotherapy, Adoptive
This is a "connection" page, showing publications MELODY HELLSTEN has written about Immunotherapy, Adoptive.
Connection Strength
0.037
-
High Symptom Burden Predicts Poorer Quality of Life Among Children and Adolescents Receiving Hematopoietic Stem Cell Transplantation or Chimeric Antigen Receptor T-Cell Therapy. Cancer Nurs. 2025 Mar-Apr 01; 48(2):E111-E120.
Score: 0.037